Suchen und filtern

Gefundene Studien

ATOMIC Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient DNA mismatch repair AIO-KRK-0317 · In Rekrutierung Studie anzeigen

FIRE-7 Impact of a centralized tumour board on secondary intervention rate in patients with RAS mutant metastatic colorectal cancer after first-line treatment with FOLFOXIRI plus bevacizumab (FIRE-7) AIO-KRK-0120 · In Rekrutierung Studie anzeigen

FIRE-8 First-line combinations of Trifluridin/Tipiracil with biologicals (FIRE-8) AIO-KRK/YMO-0519 · In Rekrutierung Studie anzeigen

PIONEER Window of opportunity study of preoperative immunotherapy with atezolizumab (Tecentriq in local squamous cell carcinoma of the head and neck – an imCORE Study AIO-KHT-0220/ass · In Rekrutierung Studie anzeigen

ABC-HCC Trial A Phase IIIb, randomized, multicenter, open-label trial of Atezolizumab plus Bevacizumab versus transarterial Chemoembolization (TACE) in intermediate-stage HepatoCellular Carcinoma AIO-HEP-0321/ass · In Rekrutierung Studie anzeigen

ADVANCE A phase II single-arm, open-label study of Atezolizumab and Derazantinib for patients with advanced intrahepatic cholangiocarcinoma with FGFR2 fusions/rearrangements - ADVANCE AIO-HEP-0221/ass · In Rekrutierung Studie anzeigen

IRITACE Transarterial chemoembolization (TACE) with Irinotecan and Mitomycin C versus TACE with Doxorubicin in patients with Hepatocellular carcinoma not amenable to curative treatment - IRITACE- a randomized multicenter phase 2 trial. A trial of the German Alliance for Liver Cancer (GALC). (IRITACE) AIO-HEP-0220/ass · In Rekrutierung Studie anzeigen

SOLARIS A phase-II open-label study of pembrolizumab and lenvatinib in patients with advanced stage hepatocellular carcinoma who are refractory to atezolizumab and bevacizumab/ IO-based therapy - SOLARIS AIO-HEP-0121/ass · In Vorbereitung Studie anzeigen

TRADEhypo Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy (TRADE-hypo) AIO-YMO/TRK-0319 · In Rekrutierung Studie anzeigen

ROSE Radiation during Osimertinib Treatment: a Safety and Efficacy Cohort Study AIO-YMO/TRK-0120 · In Rekrutierung Studie anzeigen